glp 1 ra therapy Top GLP-1 Agonists Balance Weight Loss Efficacy, Safety Rethinking GLP-1RA Therapy Through the

In orforglipron trials, approximately 30-40% of patients on the highest dose reported nausea, with most episodes rated as mild to moderate

Body weight may influence dosing for some compounds, especially weight-based dosing tied to certain FDA-approved indications

Headaches: Occasionally reported, particularly during initial use

[106] Other drugs [edit] Certain medications can decrease the absorption of orally consumed vitamin B 12 , including colchicine, extended-release potassium products, and antibiotics such as gentamicin, neomycin and tobramycin

It also stimulates gonadal activity and supports studies related to testicular function in research